BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
64 results:

  • 1. Chemokine Receptor PET/CT Provides Relevant staging and Management Changes in Marginal Zone Lymphoma.
    Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
    J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel Prognostic staging System for Patients With De Novo Metastatic Breast cancer.
    Plichta JK; Thomas SM; Hayes DF; Chavez-MacGregor M; Allison K; de Los Santos J; Fowler AM; Giuliano AE; Sharma P; Smith BD; van Eycken E; Edge SB; Hortobagyi GN
    J Clin Oncol; 2023 May; 41(14):2546-2560. PubMed ID: 36944149
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
    Mai EK; Huhn S; Miah K; Poos AM; Scheid C; Weisel KC; Bertsch U; Munder M; Berlanga O; Hose D; Seckinger A; Jauch A; Blau IW; Hänel M; Salwender HJ; Benner A; Raab MS; Goldschmidt H; Weinhold N
    Blood Cancer J; 2023 Jan; 13(1):1. PubMed ID: 36599831
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
    Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma.
    Edwards CV; Hassan H; Yildirim C; Ferri G; Verma KP; Murray Horwitz ME; Fillmore NR; Munshi NC
    Blood Adv; 2023 Feb; 7(4):482-490. PubMed ID: 36409606
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Impact of ASCO Choosing Wisely Guidelines on staging Imaging for Early-Stage Breast cancers: A Time Series Analysis Using SEER-Medicare Data.
    Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
    JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer.
    Lange SM; Choudry MM; Hunt TC; Ambrose JP; Haaland BA; Lowrance WT; Hanson HA; O'Neil BB
    Urol Oncol; 2023 Jan; 41(1):48.e19-48.e26. PubMed ID: 36307366
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.
    Desai AV; Gilman AL; Ozkaynak MF; Naranjo A; London WB; Tenney SC; Diccianni M; Hank JA; Parisi MT; Shulkin BL; Smith M; Moscow JA; Shimada H; Matthay KK; Cohn SL; Maris JM; Bagatell R; Sondel PM; Park JR; Yu AL
    J Clin Oncol; 2022 Dec; 40(35):4107-4118. PubMed ID: 35839426
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of
    Basso Dias A; Finelli A; Bauman G; Veit-Haibach P; Berlin A; Ortega C; Avery L; Metser U
    Radiology; 2022 Sep; 304(3):600-608. PubMed ID: 35608445
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pan-cancer analysis of prognostic metastatic phenotypes.
    Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
    Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.
    Pomicter AD; Clair PM; Yan D; Heaton WL; Eiring AM; Anderson MB; Richards SM; Gililland J; O'Hare T; Deininger MW
    Acta Haematol; 2021; 144(4):458-464. PubMed ID: 33412552
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate cancer.
    Deek MP; Taparra K; Dao D; Chan L; Phillips R; Gao RW; Kwon ED; Deville C; Song DY; Greco S; Carducci MA; Eisenberger M; DeWeese TL; Denmeade S; Pienta K; Paller CJ; Antonarakis ES; Olivier KR; Park SS; Stish BJ; Tran PT
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):387-395. PubMed ID: 32798608
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel staging System for De Novo Metastatic Breast cancer Refines Prognostic Estimates.
    Plichta JK; Thomas SM; Sergesketter AR; Greenup RA; Rosenberger LH; Fayanju OM; Kimmick G; Force J; Hyslop T; Hwang ES
    Ann Surg; 2022 Apr; 275(4):784-792. PubMed ID: 32657941
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017.
    Reedijk AMJ; Kremer LC; Visser O; Lemmens V; Pieters R; Coebergh JWW; Karim-Kos HE
    Eur J Cancer; 2020 Jul; 134():115-126. PubMed ID: 32521425
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information.
    Nakajima R; Moskowitz AJ; Michaud L; Mauguen A; Batlevi CL; Dogan A; Schöder H
    Blood Adv; 2020 Apr; 4(8):1812-1823. PubMed ID: 32343798
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Presalvage International staging System Stage and Other Important Outcome Associations in CD34
    Bryant AR; Hilden P; Giralt S; Chung DJ; Maloy M; Landau H; Landgren O; Scordo M; Shah G; Smith EL; O'Reilly RJ; Perales MA; Koehne G
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):58-65. PubMed ID: 31493537
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Detection of distant metastatic disease by positron emission tomography with
    Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
    Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. bone Subtraction Iodine Imaging Using Area Detector CT for Evaluation of Skull Base Invasion by Nasopharyngeal Carcinoma.
    Hiyama T; Kuno H; Sekiya K; Tsushima S; Sakai O; Kusumoto M; Kobayashi T
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):135-141. PubMed ID: 30523140
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.